Skip to main content
. 2003 Dec;163(6):2585–2593. doi: 10.1016/S0002-9440(10)63613-9

Figure 1.

Figure 1.

PrPres from patients with prion diseases and prion-inoculated Ki-ChM mice A: PrPres type 1 extracted from MM1 sCJD (H-3, lane 1). PrPres type 2 from MM2-T sCJD (NK, lane 2), and vCJD (96/02, lane 3). B: PrPres isolated from Ki-ChM mice inoculated with MM1 sCJD (H-3, lane 2), MM2-T sCJD (NK, lane 4), and vCJD (96/02, lane 6) are shown along with those from the respective inocula (H-3, lane 1; NK, lane 3; 96/02, lane 5). Ki, PrPres isolated from Ki-ChM mice; In, PrPres isolated from inocula. C: Deglycosylated PrPres isolated from Ki-ChM mice inoculated with human prion diseases (the same samples as shown in B): MM1 sCJD, lane 1; MM2-T sCJD, lane 2; vCJD, lane 3.